Article

Persistent Borna Disease Virus (BDV) infection activates microglia prior to a detectable loss of granule cells in the hippocampus

Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Journal of Neuroinflammation (Impact Factor: 4.9). 02/2008; 5:16. DOI: 10.1186/1742-2094-5-16
Source: PubMed

ABSTRACT Neonatal Borna Disease Virus (BDV) infection in rats leads to a neuronal loss in the cortex, hippocampus and cerebellum. Since BDV is a non-lytic infection in vitro, it has been suggested that activated microglia could contribute to neuronal damage. It is also conceivable that BDV-induced cell death triggers activation of microglia to remove cell debris. Although an overall temporal association between neuronal loss and microgliosis has been demonstrated in BDV-infected rats, it remains unclear if microgliosis precedes or results from neuronal damage. We investigated the timing of microglia activation and neuronal elimination in the dentate gyrus (DG) of the hippocampus. We found a significant increase in the number of ED1+ microglia cells as early as 10 days post infection (dpi) while a detectable loss of granule cells of the DG was not seen until 30 dpi. The data demonstrate for the first time that a non-lytic persistent virus infection of neurons activates microglia long before any measurable neuronal loss.

1 Follower
 · 
108 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Borna disease virus (BDV) is a neurotropic virus that produces neuropsychiatric dysfunction in a wide range of warm-blooded species. Several studies have associated BDV with human psychiatric illness, but the findings remain controversial. Although oligodendrocytes are a major glial component of brain white matter and play a pivotal role in neuronal cell function, BDV's effects on human oligodendrocytes have not been clarified. Here, the effects of two BDV strains, Hu-H1 (isolated from a bipolar patient) and Strain V (a laboratory strain), on the proliferation and apoptosis of human oligodendrocytes were investigated. Three experimental cell lines were constructed: Hu-H1-infected oligodendroglioma (Hu-H1) cells, Strain V-infected oligodendroglioma (Strain V) cells, and non-infected oligodendroglioma (control) cells. BDV infection was assayed by BDV nucleoprotein (p40) immunofluorescence, cell proliferation was assayed by Cell Counting Kit-8 (CCK8), and cell cycle phases and apoptosis were assayed by flow cytometry. Expressions of the apoptosis-related proteins Bax and Bcl-2 were measured by Western blotting. p40 expression was confirmed in Hu-H1 and Strain V on and after day three post-infection. Strain V cells showed significantly greater cellular proliferation than Hu-H1 cells on and after day three post-infection. In Hu-H1 cells, Bax and Bcl-2 expression were significantly increased and decreased, respectively, on and after day three post-infection. In contrast, in Strain V cells, Bax and Bcl-2 expression were significantly decreased and increased, respectively, on and after day three post-infection. In conclusion, Hu-H1 inhibits cellular proliferation and promotes apoptosis in human oligodendrocytes via Bax upregulation and Bcl-2 downregulation. In contrast, Strain V promotes cellular proliferation and inhibits apoptosis in human oligodendrocytes via Bax downregulation and Bcl-2 upregulation. The effects of the Hu-H1 strain (isolated from a bipolar patient) are opposite from those of Strain V (a laboratory strain), thereby providing a proof of authenticity for both.
    PLoS ONE 06/2013; 8(6):e66623. DOI:10.1371/journal.pone.0066623 · 3.53 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Functional macrophage heterogeneity is recognized outside the central nervous system (CNS), where alternatively activated macrophages can perform immune-resolving functions. Such functional heterogeneity was largely ignored in the CNS, with respect to the resident microglia and the myeloid-derived cells recruited from the blood following injury or disease, previously defined as blood-derived microglia; both were indistinguishably perceived detrimental. Our studies have led us to view the myeloid-derived infiltrating cells as functionally distinct from the resident microglia, and accordingly, to name them monocyte-derived macrophages (mo-MΦ). Although microglia perform various maintenance and protective roles, under certain conditions when they can no longer provide protection, mo-MΦ are recruited to the damaged CNS; there, they act not as microglial replacements but rather assistant cells, providing activities that cannot be timely performed by the resident cells. Here, we focus on the functional heterogeneity of microglia/mo-MΦ, emphasizing that, as opposed to the mo-MΦ, microglia often fail to timely acquire the phenotype essential for CNS repair.
    Frontiers in Cellular Neuroscience 04/2013; 7:34. DOI:10.3389/fncel.2013.00034 · 4.18 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Mild encephalitis (ME) hypothesis suggested a usually smouldering in any case low level inflammatory process in the CNS resulting in a variety of psychopathological symptoms: indeed increased proinflammatory markers like cytokines have been described in blood and CSF in patients suffering from affective or schizophrenic disorders. Animal models showed that a hit in early life to the immune system might trigger a life-long increased immune reactivity respectively vulnerability. Many epidemiological and clinical studies show the role of various infectious agents as risk factors for schizophrenia with overlap to other psychoses. The first large scale epidemiological study in psychiatry from Denmark clearly demonstrates in severe infections and autoimmune disorders during lifetime as risk factors. Genetic studies detected several risk genes in a region related to immune functions. The vulnerability–stress model matches with ME hypothesis as stress may increase proinflammatory cytokines and even contribute to lasting proinflammatory state. The immune system itself is considered an important further piece in the puzzle like in autoimmune disorders in general which are always linked to three factors: genes, environment, immune system. Alterations of dopaminergic, serotonergic, noradrenergic and glutamatergic neurotransmission have been shown with low level neuroinflammation and may directly be involved in symptom generation. Volume loss, altered brain structure and microglial activation have been demonstrated in both types of psychoses in neuroimaging studies which matches with the assumption of a low level neuroinflammatory process. Further support comes from the therapeutic benefit of anti-inflammatory medications in specific studies and only recently recognized anti-inflammatory and immunomodulatory intrinsic effects of anti-depressants and neuroleptics.
    Neurology Psychiatry and Brain Research 06/2013; DOI:10.1016/j.npbr.2013.04.004 · 0.10 Impact Factor